Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)

    Research output: Contribution to journalLiterature review

    • on behalf of all ECFS-CTN network partners

    View graph of relations

    We describe the rationale for disease specific research networks in general as well as the aims and function of the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) specifically. The ECFS-CTN was founded in 2009 with the aim of improving the quality and quantity of clinical research in the area of cystic fibrosis (CF) in Europe. A network of 18 clinical trial sites in 8 European countries was established according to uniform state-of-the-art quality criteria. To support the ECFS-CTN in the acquisition, planning and conduct of clinical trials, the network is equipped with a coordinating centre, steering and executive committees, and committees for protocol review, standardization, training and networking as well as a data safety monitoring board. A strong partnership with European CF patient parent organizations aims to increase awareness of the need for efficient clinical research and the participation of patients in clinical trials.
    Original languageEnglish
    Number of pages8
    Pages (from-to)S67-S74
    JournalJournal of Cystic Fibrosis
    Journal publication dateJun 2011
    Issue numberSuppl 2
    Publication statusPublished - Jun 2011

      Research areas

    • research network, clinical trials, cystic fibrosis

    ID: 3464213